Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APGE |
---|---|---|
09:32 ET | 2022 | 57.945 |
09:34 ET | 150 | 57.45 |
09:38 ET | 1230 | 58.72 |
09:39 ET | 100 | 58.51 |
09:43 ET | 349 | 58.76 |
09:45 ET | 100 | 58.99 |
09:48 ET | 4556 | 59.99 |
09:50 ET | 4779 | 60.07 |
09:52 ET | 100 | 59.98 |
09:54 ET | 1042 | 59.75 |
09:57 ET | 100 | 59.65 |
09:59 ET | 1821 | 59.34 |
10:01 ET | 200 | 59.325 |
10:03 ET | 100 | 59.305 |
10:06 ET | 2025 | 59.305 |
10:08 ET | 1300 | 59.305 |
10:10 ET | 662 | 59.265 |
10:12 ET | 2354 | 59.345 |
10:14 ET | 100 | 59.335 |
10:15 ET | 100 | 59.255 |
10:17 ET | 1158 | 59.235 |
10:19 ET | 1882 | 59.185 |
10:21 ET | 1000 | 59.035 |
10:24 ET | 500 | 59.045 |
10:26 ET | 2500 | 59.105 |
10:28 ET | 100 | 59.115 |
10:30 ET | 1256 | 59.52 |
10:32 ET | 2825 | 59.57 |
10:33 ET | 220 | 59.415 |
10:35 ET | 100 | 59.43 |
10:37 ET | 100 | 59.415 |
10:42 ET | 100 | 59.265 |
10:44 ET | 2900 | 59.18 |
10:48 ET | 100 | 59.125 |
10:55 ET | 700 | 59.13 |
10:57 ET | 3181 | 59.09 |
11:02 ET | 455 | 59.12 |
11:04 ET | 1000 | 59.32 |
11:06 ET | 200 | 59.26 |
11:08 ET | 1030 | 59.29 |
11:18 ET | 200 | 59.12 |
11:20 ET | 1287 | 59.37 |
11:22 ET | 1346 | 59.31 |
11:24 ET | 100 | 59.45 |
11:26 ET | 613 | 59.34 |
11:27 ET | 375 | 59.3 |
11:29 ET | 400 | 59.35 |
11:33 ET | 200 | 59.34 |
11:36 ET | 200 | 59.265 |
11:38 ET | 200 | 59.33 |
11:40 ET | 1910 | 59.11 |
11:42 ET | 1600 | 59.015 |
11:44 ET | 200 | 59.02 |
11:45 ET | 900 | 59.04 |
11:47 ET | 200 | 59.04 |
11:51 ET | 100 | 59.12 |
11:54 ET | 100 | 59.035 |
12:00 ET | 100 | 59.14 |
12:02 ET | 100 | 59.03 |
12:05 ET | 200 | 59.04 |
12:07 ET | 700 | 58.955 |
12:09 ET | 131 | 58.965 |
12:12 ET | 533 | 58.85 |
12:14 ET | 150 | 58.85 |
12:16 ET | 450 | 58.87 |
12:18 ET | 986 | 58.93 |
12:20 ET | 1200 | 58.86 |
12:21 ET | 1640 | 58.86 |
12:23 ET | 500 | 58.87 |
12:25 ET | 200 | 58.79 |
12:27 ET | 573 | 58.84 |
12:30 ET | 500 | 58.84 |
12:32 ET | 668 | 58.95 |
12:36 ET | 1000 | 58.69 |
12:38 ET | 2938 | 58.74 |
12:39 ET | 300 | 58.73 |
12:41 ET | 4303 | 58.92 |
12:43 ET | 100 | 58.8 |
12:50 ET | 100 | 58.92 |
12:54 ET | 100 | 58.91 |
12:57 ET | 603 | 58.765 |
12:59 ET | 635 | 58.785 |
01:01 ET | 1056 | 58.85 |
01:03 ET | 204 | 58.78 |
01:06 ET | 100 | 58.78 |
01:08 ET | 1328 | 58.525 |
01:12 ET | 100 | 58.33 |
01:14 ET | 256 | 58.34 |
01:15 ET | 100 | 58.09 |
01:19 ET | 600 | 58.1 |
01:28 ET | 200 | 58 |
01:32 ET | 1086 | 57.97 |
01:33 ET | 100 | 57.97 |
01:35 ET | 1096 | 58.09 |
01:39 ET | 100 | 58.19 |
01:44 ET | 100 | 58.04 |
01:51 ET | 100 | 58.02 |
01:53 ET | 1000 | 58.38 |
01:57 ET | 1556 | 58.33 |
02:00 ET | 200 | 58.32 |
02:08 ET | 2322 | 58.29 |
02:11 ET | 1390 | 58.38 |
02:13 ET | 800 | 58.175 |
02:15 ET | 300 | 57.97 |
02:18 ET | 100 | 57.89 |
02:20 ET | 3900 | 57.835 |
02:22 ET | 2950 | 57.605 |
02:24 ET | 700 | 57.49 |
02:26 ET | 100 | 57.43 |
02:27 ET | 1122 | 57.61 |
02:31 ET | 200 | 57.615 |
02:33 ET | 200 | 57.6 |
02:47 ET | 450 | 57.82 |
02:54 ET | 1700 | 58.38 |
02:58 ET | 100 | 58.13 |
03:02 ET | 923 | 57.97 |
03:05 ET | 3564 | 58.01 |
03:09 ET | 400 | 58.09 |
03:14 ET | 100 | 58.175 |
03:16 ET | 674 | 58.17 |
03:18 ET | 100 | 58.28 |
03:21 ET | 3645 | 58.2 |
03:23 ET | 100 | 58.23 |
03:27 ET | 100 | 58.235 |
03:30 ET | 100 | 58.17 |
03:32 ET | 100 | 58.265 |
03:34 ET | 700 | 58.14 |
03:36 ET | 2700 | 58.185 |
03:38 ET | 321 | 58.23 |
03:39 ET | 300 | 58.265 |
03:41 ET | 205 | 58.16 |
03:48 ET | 581 | 58.155 |
03:50 ET | 3000 | 58.17 |
03:52 ET | 1700 | 58.4528 |
03:54 ET | 8431 | 58.5325 |
03:56 ET | 5394 | 58.92 |
03:57 ET | 2297 | 58.89 |
03:59 ET | 182023 | 58.74 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Apogee Therapeutics Inc | 3.4B | -26.2x | --- |
Dyne Therapeutics Inc | 3.6B | -10.0x | --- |
MoonLake Immunotherapeutics | 3.2B | -55.8x | --- |
Merus NV | 3.4B | -17.4x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Xenon Pharmaceuticals Inc | 3.0B | -14.4x | --- |
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immunology (I&I) indications with high unmet need. Its advanced programs are APG777 and APG808, which are developed for the treatment of AD and COPD, respectively. APG777 is a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) targeting IL-13. APG808 is an SQ extended half-life mAb targeting IL-4Rα. Its earlier-stage programs, APG990 and APG222, utilize advanced antibody engineering to target OX40L and both IL-13 and OX40L, which are developed for the treatment of AD. APG990 is an SQ extended half-life mAb targeting OX40L for the treatment of AD. APG222 is one or more extended half-life SQ antibodies targeting both IL-13 and OX40L, which has the potential to improve outcomes in AD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.4B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 58.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.25 |
Book Value | $7.86 |
P/E Ratio | -26.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.